CanSino Biologics Inc. (HKG:6185)
Hong Kong · Delayed Price · Currency is HKD 25.80
-1.04 (-3.87%)
Sep 11, 2026, 4:08 PM HKT
CanSino Biologics Stock Forecast
Stock Price Forecast
According to 4 analysts polled by S&P Global, CanSino Biologics stock has a consensus rating of "Strong Buy" and an average price target of $47.54. The average 1-year stock price forecast is 84.26% higher than the current stock price, while the lowest is $44.31 (+71.74%) and the highest is $49.75 (+92.83%).
Price Target: $47.54 (+84.26%)
Analyst Consensus: Strong Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for CanSino Biologics stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jan '26 | Mar '26 | Apr '26 | Jun '26 | Jul '26 | Aug '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 4 | 3 | 3 | 3 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 4 | 4 | 5 | 4 | 4 | 4 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
Unknown Analyst Citic Securities No rating | Citic Securities | Buy Maintains $46.00 | Buy | Maintains | $46.00 | +78.29% | Sep 8, 2026 |
Unknown Analyst CLSA No rating | CLSA | Buy Maintains $53.20 | Buy | Maintains | $53.20 | +106.20% | Aug 26, 2026 |
Unknown Analyst UBS No rating | UBS | Buy Maintains $52.40 | Buy | Maintains | $52.40 | +103.10% | Jun 25, 2026 |
Financial Forecast
Revenue This Year
1.44B
from 1.07B
Increased by 34.87%
Revenue Next Year
1.81B
from 1.44B
Increased by 25.82%
EPS This Year
0.52
from 0.16
Increased by 217.32%
EPS Next Year
1.52
from 0.52
Increased by 193.17%
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is CNY.